Nutraceuticals show promise in oral cancer therapy
Two nutraceuticals — green tea extracts and resveratrol — have shown promise in treating various cancers, including oral squamous cell carcinoma (OSCC). But the limited
Two nutraceuticals — green tea extracts and resveratrol — have shown promise in treating various cancers, including oral squamous cell carcinoma (OSCC). But the limited
Researchers have completed a phase II clinical trial that may help identify patients with human papillomavirus (HPV)-positive oropharyngeal cancer who do not require the full
Patients with metastatic or recurrent forms of head and neck cancer respond better to systemic treatments if their tumors arise in association with the human
Just one alcoholic drink a day increases the chances of developing cancer, according to a presentation this week at an Irish Cancer Society conference. Drinking
Midlevel dental providers who are trained to provide fillings do so competently and safely, according to a new study in the Journal of Dental Research
Gastric reflux increases the risk for laryngopharyngeal squamous cell carcinoma (LPSCC), but antacids may provide protection, according to a new study in Cancer Epidemiology, Biomarkers
Routine esophageal screening can increase the early detection of second primary esophageal squamous cell carcinoma and is particularly recommended for patients with head and neck
More effective detection and diagnosis of oral cancer could result from an advance in noninvasive imaging of epithelial tissue, according to a study in Journal
Smokers do not receive oral cancer exams at a rate consistent with their risk of developing oral cancer, according to a new study in the
HuangshanDental.com is pleased to present the next installment of Leaders in Dentistry, a series of interviews with researchers, practitioners, and opinion leaders who are influencing
CDx Diagnostics has released data that support the company’s WATS3D (wide-area transepithelial sample biopsy with 3D analysis) as an additional surveillance tool to increase detection
A new measure of the heterogeneity of cells within a tumor appears to predict treatment outcomes of patients with the most common type of head